{"id":131183,"date":"2026-08-25T07:40:15","date_gmt":"2026-08-25T07:40:15","guid":{"rendered":"https:\/\/www.europesays.com\/korea\/131183\/"},"modified":"2026-08-25T07:40:15","modified_gmt":"2026-08-25T07:40:15","slug":"samsung-electronics-sk-hynix-symtech-and-alteogen-were-the-most-net-buyers-by-high-yield-investor","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/korea\/131183\/","title":{"rendered":"Samsung Electronics, SK Hynix, Symtech, and Alteogen were the most net buyers by high-yield investor.."},"content":{"rendered":"

[Stock record net buying trend on Aug. 25]
Samjeonix purchases turned higher in the afternoon, ranking 1st and 2nd, and Hanmi Pharmaceutical plunged 7% after the upper limit <\/p>\n

\"Samsung's \uc0ac\uc9c4 \ud655\ub300 Samsung’s Seocho office. [Yonhap News] \"Top \uc0ac\uc9c4 \ud655\ub300 Top 10 Net Purchases at 2:30 p.m. on Aug. 25. [Mirae Asset Securities] <\/p>\n

Samsung Electronics, SK Hynix, Symtech, and Alteogen were the most net buyers by high-yield investors trading at Mirae Asset Securities on the afternoon of the 25th.<\/p>\n

According to Mirae Asset Securities, Samsung Electronics was the most net buyers of its stock trading customers by 2:30 p.m. on the same day, with the top 1% return on investment in the past month.<\/p>\n

Samsung Electronics shares, which had been weak throughout the morning, have shifted upward in the afternoon. It is showing great volatility ahead of the announcement of Nvidia’s earnings on the 26th.<\/p>\n

Samsung Electronics decided to implement a shareholder return plan worth 90 trillion won to 110 trillion won, more than five times the previous largest annual scale.<\/p>\n

However, foreign institutions and others were disappointed that the expected large-scale share buybacks and incineration did not materialize.<\/p>\n

Choi Bo-young, a researcher at Kyobo Securities Co., said, “The market has been paying attention to how strong the semiconductor industry and the surge in FCF (surplus cash flow) will lead to further reductions. As a result, expectations that the scale could be expanded to 140 trillion won were reflected,” he explained.<\/p>\n

The second-largest net buyer was SK Hynix, another market bellwether. SK Hynix’s stock price has also succeeded in turning upward in the afternoon.<\/p>\n

Currently, SK Hynix is the most advanced in the HBM market. In the first quarter of this year, SK Hynix accounted for 58 percent of the global HBM market, far exceeding 21 percent of Samsung Electronics and Micron, respectively. It also maintains its position as a major HBM supplier for Nvidia.<\/p>\n

HBM4 is also already linked to sales. In its second-quarter earnings report last month, SK Hynix said it started mass production of HBM4 in the second quarter and will expand production in the second half of the year.<\/p>\n

It has completed long-term supply contracts (LTAs) with about 10 locations, including major strategic customers, and is also discussing multi-year contracts with other customers. The shipment of HBM4E samples was also completed in the first half of the year.<\/p>\n

Simtech was the third-largest net buyer. Symtech shares are showing a rise of more than 9% from the previous trading day as of this time. Symtech is a printed circuit board (PCB) company that was divided into human beings from Symtech Holdings in 2015.<\/p>\n

\"Top \uc0ac\uc9c4 \ud655\ub300 Top 10 Net Short Interests at 2:30 p.m. on Aug. 25. [Mirae Asset Securities] <\/p>\n

On the other hand, Hanmi Pharmaceutical sold the most shares. Hanmi Pharmaceutical, which hit the upper limit of the previous day, is weakening by 7%.<\/p>\n

On the previous day, Hanmi Pharmaceutical signed a contract with Genentech, a subsidiary of Roche Group, to transfer global rights of HM17321, excluding Korea, for up to $2.3 billion (about 3.2 trillion won).<\/p>\n

This contract is the largest among technology export cases signed by domestic pharmaceutical and bio companies as a new drug candidate.<\/p>\n

Hanmi Pharmaceutical’s contract worth about 4.8 trillion won with Sanofi in 2015 was a case of transferring three new diabetes drug candidates at once.<\/p>\n

Stock supervisors then sold out in the order of Samsung SDI, Silicon-Too, APR and Cellid, the report showed.<\/p>\n","protected":false},"excerpt":{"rendered":"[Stock record net buying trend on Aug. 25]Samjeonix purchases turned higher in the afternoon, ranking 1st and 2nd,…\n","protected":false},"author":2,"featured_media":131184,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[53486,39898,2668,2295,50729,276,66150,241,275,16973],"class_list":["post-131183","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sk-hynix","tag-10-items","tag-hanmi-pharmaceutical","tag-hynix","tag-nvidia","tag-samjeonics","tag-samsung-electronics","tag-seocho-office","tag-sk","tag-sk-hynix","tag-yonhap-news"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/posts\/131183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/comments?post=131183"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/posts\/131183\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/media\/131184"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/media?parent=131183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/categories?post=131183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/tags?post=131183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}